The headlines following a 23 September hearing featuring US Food & Drug Administration Commissioner Stephen Hahn certainly are not the type of thing that breeds confidence.
Just hours after Hahn testified about FDA’s commitment to rigorous scientific standards in the review of potential COVID-19 vaccine candidates,...






